Advisor Group Holdings, Inc. Akero Therapeutics, Inc. Transaction History
Advisor Group Holdings, Inc.
- $40.6 Billion
- Q2 2024
A detailed history of Advisor Group Holdings, Inc. transactions in Akero Therapeutics, Inc. stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 1,100 shares of AKRO stock, worth $32,681. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,100
Previous 2,978
63.06%
Holding current value
$32,681
Previous $75,000
66.67%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding AKRO
# of Institutions
170Shares Held
72.7MCall Options Held
178KPut Options Held
164K-
Janus Henderson Group PLC London, X06.88MShares$204 Million0.09% of portfolio
-
Black Rock Inc. New York, NY5.59MShares$166 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY5.43MShares$161 Million2.13% of portfolio
-
General Atlantic LLC New York, NY5.23MShares$156 Million3.88% of portfolio
-
Wellington Management Group LLP Boston, MA5.11MShares$152 Million0.02% of portfolio
About Akero Therapeutics, Inc.
- Ticker AKRO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,417,600
- Market Cap $1.38B
- Description
- Akero Therapeutics, Inc., a cardio-metabolic nonalcoholic steatohepatitis (NASH) company, engages in the development of medicines designed to restore metabolic balance and improve overall health. The company's lead product candidate is efruxifermin (EFX), an analog of fibroblast growth factor 21, which protects against cellular stress and regula...